Abbott Laboratories is rebounding from last year’s manufacturing shutdown of its U.S. baby formula plant thanks to strong medical device sales taking the place of lost revenue of COVID-19 tests.
Subscribe to:
Post Comments (Atom)
< + > Building the Healthcare AI Infrastructure Needed for the Next Era of Care
In a recent video interview with Healthcare IT Today, experts from two healthcare technology companies focus on the latest happenings with h...
No comments:
Post a Comment